The CDC is recommending a groundbreaking drug to help prevent HIV, as advocates urged CVS Health to reverse a recent decision ...
The Philippines is in the grip of its largest HIV outbreak on record, with 57 new infections reported every day, nearly a third of them among people below 18 years old, Health Secretary Ted Herbosa ...
As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling out a corresponding awareness campaign ...
In September 2021, Victoria Roscow from Manchester received a diagnosis of Human Immunodeficiency Virus (HIV) when she was nine weeks pregnant with her son. Since then, she's used social media to ...
Patients had better linkage to care for HIV and HIV was more frequently diagnosed when it was tested alongside other sexually transmitted infections (STIs), such as chlamydia and gonorrhea. The study ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
The National Institutes of Health placed a big bet on Oregon scientist Jonah Sacha this week, awarding Sacha and his colleagues an $8.4 million, five-year grant for their work developing a cure for ...
Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...
Botswana has been getting a lot of calls lately from across the African continent, prodding the nation — once “at risk of extinction” from HIV — to tell the world how they did the impossible: squash ...
Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...
JOHANNESBURG (AP) — On a warm evening in Johannesburg, the news spread like wildfire among sex workers: Within 24 hours, several nonprofit clinics providing free HIV services would be closing as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results